Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Slow Pace Of Commenting On National Priorities And Research Agenda Concerns PCORI Board

Executive Summary

As of March 1, the Patient-Centered Outcomes Research Institute has received 101 comments on its national priorities and research agenda. Despite expectation of more comments arriving at the March 15 deadline, board members expressed concern on whether enough stakeholders were reached.

You may also be interested in...



PCORI Research Applications: Fewer Than Expected, Geographically Limited

The Patient-Centered Outcomes Research Institute will look for more ways to engage the research community, particularly in Midwestern states, as the number of applications for research grants has fallen short of expectations.

PhRMA, BIO Recommendations To PCORI Emphasize Studying Delivery Of Care Rather Than Comparing Products

The Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization target data on health care delivery in their recommendations for what the Patient-Centered Outcomes Research Institute should focus its attention on.

PCORI Draft Research Agenda Offers Broad Areas Of Study With Intention Of Getting Specifics From Public Comments

The Patient-Centered Outcomes Research Institute’s issues its draft national priorities and research agenda for comment Jan. 23. Rather than identify specific research items, the list contains five broad areas designed to elicit the greatest amount of input from stakeholders on what projects should be funded for investigation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054281

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel